Maximising the Taste and Health Value of Plant Food Products (MAXVEG)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Per Bendix Jeppesen, Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT01397942
First received: July 18, 2011
Last updated: March 10, 2015
Last verified: March 2015
  Purpose

To investigate if a high dietary intake of bitter and strong tasting vegetables have positive health effects (insulin sensitivity, glucose tolerance, central obesity, fasting and postprandial lipid profile, blood pressure, vitamin D status and inflammatory markers, biomarkers of oxidative stress) on subjects with T2D. Also to look at a high dietary intake of mild and sweet modern vegetables or a normal western diet.


Condition Intervention
Type 2 Diabetes
Other: Diet intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Maximising the Taste and Health Value of Plant Food Products - Impact on Vegetable Consumption, Consumer Preferences and Human Health Factors.

Resource links provided by NLM:


Further study details as provided by Aarhus University Hospital:

Primary Outcome Measures:
  • Insulin sensitivity [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Measured as the AUC from an Oral Glucose Tolerance Test


Secondary Outcome Measures:
  • Urine and blood samples [ Time Frame: 2 years ] [ Designated as safety issue: No ]

    The fasting blood samples will be analyzed for: glucose, insulin, glucagon, HbA1c, lipids (triglycerides, HDL-, LDL- and total cholesterol), cytokines (, adipokines biomarkers of oxidative stress parathyroid hormone, vitamin D and GLP-1.

    Urine samples for metabolomics (isoprostanes and water-soluble metabolites).



Enrollment: 92
Study Start Date: May 2011
Study Completion Date: January 2015
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Diet intervention - Ancient vegatables
A healthy Nordic diet with high content of bitter strong tasting vegetables and cabbages.
Other: Diet intervention
The participants in the two experimental arms will each have to consume 500 g of vegetables and cabbages daily.
Other Names:
  • Vegetables
  • Ancient
  • Cabbages
  • Type 2 diabetes
No Intervention: Control Nordic diet
A diet habitually consumed in the Nordic countries
Experimental: Diet intervention - Modern Vegetables
A healthy Nordic diet with high content of sweet and mild tasting vegetables and cabbages.
Other: Diet intervention
The participants in the two experimental arms will each have to consume 500 g of vegetables and cabbages daily.
Other Names:
  • Vegetables
  • Ancient
  • Cabbages
  • Type 2 diabetes

Detailed Description:

The metabolic syndrome (MS), type 2 diabetes (T2D) and obesity are the world's most prevalent lifestyle diseases. This unfortunate development is mainly caused by lifestyle choices leading to obesity due to physical inactivity and excessive calorie intake.

Vegetables are an important part of the human diet and a major source of biologically active substances which determine the nutritional quality of food, color, taste, smell, antioxidative, anticarcinogenic, antihypertensive, anti-inflammatory, antihyperglycemia, immunostimulating and cholesterol-lowering properties.

Diet, as one aspect of lifestyle, is thought to be one of the modifiable variable risk factors for the development of MS and T2D, but more information is needed as to which components of the diet could be protective for the development and progression of MS and T2D with all its complications.

The study will be carried out as a 3-month randomized controlled parallel intervention study involving 60 subjects with T2D. During the fall year 2011 30 (10 in each group) subjects will participate and the remaining 30 subjects (10 in each group) in the fall 2012. The subjects will be randomized into 3 different diets:

  1. A) "A healthy Nordic diet" with high content of bitter strong tasting vegetables and cabbages.
  2. B) "A healthy Nordic diet" with high content of sweet and mild tasting vegetables and cabbages.
  3. C) A diet habitually consumed in the Nordic countries (normal control diet). The subjects in groups A and B will each have to consume 500 g root vegetables and cabbages daily which will be handed out once a week. The participants will visit the study clinic at screening, and then once weekly during the intervention period (12 weeks). Beside the screening examination there will be 3 major visits (0, 6 and 12 weeks) where the participants will collect urine samples, complete a 3-day weighed food diary (to control diet intake) and undergo clinical examination incl. measuring of blood pressure, body composition and collection of fasting blood samples i.e. glucose, insulin, glucagon, HbA1c, GLP-1, lipids (triglycerides, HDL-, LDL- and total cholesterol), cytokines, adipokines, parathyroid hormone and vitamin D. During first (week 0) and third (week 12) major visit a 120 minutes oral glucose tolerance test is included collecting blood to analyze for glucose, insulin and triglycerides.

The study will contribute to the understanding on the impact of a diet with a high level of root vegetables and cabbages with either high or low levels of phytochemicals. Furthermore, the results can be used to develop new recommendations targeted T2D and MS subjects, and thereby contribute to a healthier lifestyle and to prevent any further development and progression of these lifestyle diseases. The overall perspective of the MAXVEG project is to enhance the consumption and production of bitter and strong tasting health promoting root vegetables and cabbages with high phytochemical content and high consumer preferences targeted specific consumer groups

  Eligibility

Ages Eligible for Study:   30 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Type 2 diabetes in diet treatment or on oral anti-diabetic drug or the metabolic syndrome.

Exclusion Criteria:

  • Other severe diseases or in treatment with insulin, GLP-1 analogs, glitazones.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01397942

Locations
Denmark
Hospital Vendsyssel, Center for Clinical Research
Hjørring, Nordjylland, Denmark, 9800
Sponsors and Collaborators
Aarhus University Hospital
Investigators
Principal Investigator: Per B Jeppesen, Prof. PhD University of Aarhus
  More Information

Additional Information:
No publications provided

Responsible Party: Per Bendix Jeppesen, Associate prof., PhD, Aarhus University Hospital
ClinicalTrials.gov Identifier: NCT01397942     History of Changes
Other Study ID Numbers: 09-067129
Study First Received: July 18, 2011
Last Updated: March 10, 2015
Health Authority: Denmark: Ethics Committee

Keywords provided by Aarhus University Hospital:
Diet intervention
Type 2 diabetes
Vegetables
Phytochemicals

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on July 05, 2015